Study reveals a fluorescent peptide probe's capability to target mitochondria and assess dysfunction in cellular environments.
Peptide self-assembly has emerged as a highly regarded strategy for developing functional agents to control cellular fate. However, due to the complexity of intracellular environments, achieving spatiotemporally traceable organelle localization and functional perturbation through peptide self-assembly remains a challenge. In this study, we developed T-FFVLK, a fluorescent peptide probe that integrates a red-emitting mitochondria-targeted molecule with a self-assembling peptide for visual tracking. This probe sequentially enters cellular compartments, ultimately targeting mitochondria to form disruptive self-assembled structures while reporting mitochondrial dysfunction. Once endocytosed into the cell, T-FFVLK initially forms short fibers that promote lysosomal escape, subsequently entering the mitochondria, where it further forms long fibers, all accompanied by a gradual increase in fluorescence and self-reporting of probe localization and mitochondrial dysfunction. T-FFVLK achieves mitochondrial enrichment within 6 h and induces morphological and functional changes within 12 h, leading to microtubule damage and cell cycle arrest. Thus, T-FFVLK is an invaluable tool for the observation of mitochondrial dysfunction in living cells, offering great potential for subcellular imaging and disease treatment.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: